Table 4.
HRQOL (SF-36) adjusted mean values in vertebral and hip fracture groups at seven-year follow-up
| SF-36 |
Vertebral group n = 42 |
Hip group n = 25 |
p-value* |
| PF | 51.6 (44.5-58.8)a | 56.0 (46.7-65.4) | p = 0.464 |
| RP | 30.5 (20.0-41.1) | 35.7 (21.8-49.5) | p = 0.563 |
| BP | 42.9 (36.1-49.6) | 58.5 (49.7-67.3) | p = 0.007 |
| GH | 56.2 (49.3-63.1) | 64.9 (55.9-73.9) | p = 0.136 |
| VT | 48.5 (42.3-54.7) | 62.3 (54.2-70.4) | p = 0.010 |
| SF | 68.5 (61.1-75.9) | 80.4 (70.7-90.0) | p = 0.060 |
| RE | 54.7 (42.0-67.3) | 78.9 (62.3-95.4) | p < 0.026 |
| MH | 71.2 (65.4-77.1) | 82.7 (75.0-90.4) | p < 0.023 |
PF: Physical Functioning, RP: Role-Physical, BP: Bodily Pain, GH: General Health,
VT: Vitality, SF: Social Functioning, RE: Role-Emotional, MH: Mental Health.
a Values in parentheses correspond to 95% confidence intervals.
*Significant tests: ANCOVA, means controlling for the effect of covariates, age, new co-morbidity, and new fracture since two-year follow-up.
Significance level p < 0.05 is given in bold.